Displaying drugs 4576 - 4600 of 5959 in total
Phloretic acid
Experimental
Tideglusib
Tideglusib is under the investigation for the development of treatments for Alzheimer's disease and for progressive supranuclear palsy. It is reported to be a potent anti-inflammatory and neuroprotective that is a non-ATP competitive inhibitor of glycogen synthase kinase 3 (GSK-3). Tideglusib is being developed by the Spanish pharmaceutic company Zeltia...
Investigational
Withdrawn
Hexadecanesulfonyl fluoride
Experimental
Clevudine
Investigational
2-Acetyl-Protoporphyrin Ix
Experimental
3-(4-NITRO-PHENOXY)-PROPAN-1-OL
Experimental
Zelavespib
Zelavespib (PU-H71) has been used in trials studying the treatment of LYMPHOMA, Solid Tumors, Metastatic Solid Tumor, and Myeloproliferative Neoplasms (MPN).
Investigational
Doxifluridine
Doxifluridine has been investigated for the treatment of Stomach Cancer.
Investigational
Azapropazone
Withdrawn
Methylpropylpropanediol dinitrate
Experimental
Lactobacillus fermentum
Experimental
Glycerol 2-phosphate
Experimental
Elsubrutinib
Elsubrutinib is under investigation in clinical trial NCT04451772 (A Study of the Safety of Oral Elsubrutinib Capsules and Oral Upadacitinib Tablets Given Alone or in Combination (ABBV-599) for Adult Participants With Moderately to Severely Active Systemic Lupus Erythematosus to Assess Change in Disease State).
Investigational
Crotonaldehyde
Experimental
1-hydroxy-2-isopropylguanidine
Experimental
1-(3-bromophenyl)-7-chloro-6-methoxy-3,4-dihydroisoquinoline
1-(3-bromophenyl)-7-chloro-6-methoxy-3,4-dihydroisoquinoline is a solid. This compound belongs to the isoquinolines and derivatives. These are aromatic polycyclic compounds containing an isoquinoline moiety, which consists of a benzene ring fused to a pyridine ring and forming benzo[c]pyridine. This medication is known to target mitogen-activated protein kinase 10.
Experimental
Matched Description: … This medication is known to target mitogen-activated protein kinase 10. …
Bemarituzumab
Bemarituzumab is under investigation in clinical trial NCT03694522 (A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 (Mfolfox6) in Gastric/gastroesophageal Junction Cancer (FIGHT)).
Investigational
AF-710B
Investigational
Miridesap
Miridesap has been used in trials studying the prevention of HIV and treatment of AL amyloidosis.
Investigational
Estriol tripropionate
Experimental
KUS-121 free acid
Investigational
Octenidine
Octenidine is under investigation in clinical trial NCT02697162 (Antiseptic-coated Intermittent Urinary Catheter).
Investigational
Matched Categories: … Respiratory System …
Displaying drugs 4576 - 4600 of 5959 in total